70-640 exam 70-642 exam 70-643 exam 70-647 exam 70-680 exam 70-432 exam 70-450 exam 70-646 exam 70-410 exam 70-411 exam 70-412 exam 70-461 exam 70-462 exam 70-463 exam 70-466 exam 70-467 exam 70-413 exam 70-414 exam 1Z0-051 exam 1Z0-052 exam 1Z0-053 exam 1z0-042 exam 1z0-047 exam 1z0-043 exam 1Z0-144 exam 1Z0-146 exam 642-902 exam 642-832 exam 642-813 exam 642-427 exam 642-437 exam 642-447 exam 642-457 exam 642-467 exam 300-206 exam 300-207 exam 300-208 exam 300-209 exam C4040-108 exam C4040-109 exam C4040-221 exam C4090-451 exam C4040-332 exam 220-701 exam 220-702 exam LX0-101 exam LX0-102 exam HP0-P20 exam HP0-P19 exam HP0-P21 exam 700-505 640-911 M70-301 70-489 700-501 M70-101 70-458 70-341 70-464 70-680 74-335 70-687 70-457 n10-005 1z0-061 220-801 70-465 exam C4090-958 MB2-867J MB2-868 MB2-876 MB3-207 MB3-208 MB3-209 MB3-210 MB3-214 MB3-215 MB3-216 MB3-230 P2060-001 P2060-002 P2060-017 P2070-055 P2070-071 P2070-072 VCAW510 VCP-310 VCP-410 VCP-411 VCP-510 VCP-511 VCP-550 1Z1-821 1Z1-822 1Z1-850 1Z1-851 74-353 74-404 74-409 74-674 74-676 70-410 70-460 70-461 70-462 200-120 70-488 MB2-703 70-411 mb5-705 70-346 70-486 70-347 70-480 70-483 70-412 70-463 mb2-700 3X0-203 3X0-204 400-051 400-101 500-005 500-051 500-201 500-254 500-285 510-014 510-015 810-420 820-421 820-422 83-640 850-001 920-093 A2040-986 A2040-988 A2050-219 A2050-723 BR0-002 BR0-003 C_A1FIN_10 C_BOCR_08 CX-310-019 CX-310-027 CX-310-052 CX-310-053 MB2-498 MB2-631 MB2-632 MB2-633 MB2-634 MB2-700 MB2-701 MB2-702 MB2-703 MB2-866 MB2-867 windows 7 key windows 7 key windows 7 key windows 7 key Windows-8-Enterprise-Key Windows-8-Enterprise-Key-sale cheap-Windows-8-Key Windows-8-1-Key Windows-8-Standard-Key Windows-8-Standard-Key-online buy-Windows-8-Standard-Key windows-7-key buy-windows-7-key windows-7-key-sale cheap-windows-7-key-for-sale windows-7-key-sale-oem windows-7-key-sale-finmde buy-Windows-8-Key windows-7-key-for-sale cheap-windows-7-key-sale windows-7-ultimate-serial-product 18630-product-key-number windows-7-all-number windows-7-product-keys windows-8-professional-product-keys windows-8-product-keys-serial-keys windows-8-professional-product-key windows-8-product-key Office-2013-Professional-Key Office-2010-Professional-Key windows81-product-key Office-2013-Professional-Key Office-2010-Professional-Key windows 7 key windows 7 key windows 8 key windows 7 key windows 7 key windows 7 key windows 7 key windows 8 key windows 8 key windows 8 key windows 8 key windows 8 key windows 8.1 key windows 7 key windows 7 key windows 7 key windows 7 key windows 7 key
Wiley-Blackwell To Launch Archives Of Drug Information - EWORLDWIRE

Why EworldwireTM

Get Direct Delivery : Send your press release via the highest regarded and respected PR newswire service. All media targeting services - from writing, to video, podcast and photo - are provided in-house by the ONLY BUSINESS WIRE TO OFFER THESE SERVICES COMPLETELY IN-HOUSE. ARCHIVE YOUR PRESS RELEASE INDEFINITELY - NOT JUST 7 OR 30 DAYS- and benefit from the long-term long tail impact of your news release when the public is searching online, with no hidden costs.

Login

logo

Wiley-Blackwell
Internet:
vfoley@bos.blackwellpublishing.com

Company Information :
Wiley-Blackwell
350 Main Street
Malden, MA 02148
USA
Ph. 781-388-8334
Fx. 781-338-8334

Wiley-Blackwell To Launch Archives Of Drug Information

Journal Increases Public Access to Latest Research from Pharmaceutical Industry: Wiley-Blackwell announced the launch of Archives of Drug Information (ADI), a new open access, freely available peer-reviewed journal.

For Immediate Release

MALDEN, Mass./EWORLDWIRE/March 5, 2007 --- Wiley-Blackwell announced the launch of Archives of Drug Information (ADI), a new open access, freely available peer-reviewed journal, dedicated to publishing the results of drug studies. This journal will help to address requests for transparency voiced by societies, health care practioners, patients, media, and the government to disclose clinical trial information.

ADI is unique because it will publish not only results of clinical trials and drug studies but also articles on inconclusive and/or negative clinical trials, early drug development, routine drug-drug interaction, pharmacokinetic studies, and other low-profile areas that are traditionally overlooked. The first articles will be published online April 2007.

"ADI will provide an unbiased, scientific home for high-quality information that should be in the public domain but currently resides on file somewhere," says Dr. C. Michael Stein, editor of Archives of Drug Information. 'It will also help prevent scientists in drug development from repeating mistakes or following the same blind alleys others have explored because that information has never been published." ADI will publish a broad range of research, including cellular, animal, and human studies.

While some government and pharmaceutical companies provide repositories to register clinical data and public databases to post clinical trial results, sources for independent publication are very limited. As a result, the findings of many drug development studies and clinical trials remain unpublished. Archives of Drug Information will bridge this gap by publishing data from clinical trials thereby disclosing results promptly to the researcher, clinician and the public. With ADI, it will be possible for everyone to freely search every published article to locate specific trials, methods, and experimental results.

"This new journal is an exciting opportunity for Wiley-Blackwell to help the medical and pharmaceutical communities advance the innovative work of drug discovery and to help patients and their families understand the risks and benefits of prescription medicines," says Sue Corbett, vice president and managing director, Medicine, Wiley-Blackwell. "Archives of Drug Information will become a resource for scientists, physicians, patients, and students worldwide by providing free access to information that has previously been inaccessible.”

For more information on submitting papers to ADI, contact ADI@bos.blackwellpublishing.com.

About Wiley-Blackwell

Wiley-Blackwell was formed in February 2007 as a result of the merger between Blackwell Publishing Ltd. and John Wiley & Sons, Inc.'s Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,250 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, visit 'http://www.blackwellpublishing.com' or 'http://interscience.wiley.com'.

About Wiley

Founded in 1807, John Wiley & Sons, Inc. provides must-have content and services to customers worldwide. Wiley's core businesses include scientific, technical and medical journals, encyclopedias, books and online products and services; professional and consumer books and subscription services; and educational materials for undergraduate and graduate students and lifelong learners. Wiley has publishing, marketing and distribution centers in the U.S., Canada, Europe, Asia and Australia. Wiley's European operations are based in Chichester, U.K. The company is listed on the New York Stock Exchange under the symbols JWa and JWb. Wiley's Internet site can be accessed at 'http://www.wiley.com'.

HTML:   http://www.eworldwire.com/pressreleases/16578
PDF:   http://www.eworldwire.com/pdf/16578.pdf
MOBILE:    http://www.eworldwire.com/mobile/16578
ONLINE NEWSROOM:   http://www.eworldwire.com/newsroom/311666.htm

NEWSROOM RSS FEED:   http://newsroom.eworldwire.com/xml/newsrooms/311666.xml
LOGO:   http://www.eworldwire.com/newsroom/311666.htm

CONTACT:
Virginia Foley
Wiley-Blackwell
350 Main Street
Malden, MA 02148
PHONE. 781-388-8334
EMAIL: vfoley@bos.blackwellpublishing.com
http://www.blackwellpublishing.com

KEYWORDS: Wiley-Blackwell, John Wiley and Sons, Blackwell Publishing, pharmaceutical, drug information, peer-reviewed, journal, drug development, pharmacokinetic

SOURCE: Wiley-Blackwell


(Top)

    • Featured

  • Client Login

    Forgot Password?
  • Newsletter